SIGMAR1 and Huntington disease: The evidence for the Sigmar1’s role in HD pathology was provided by the initial in vitro studies in which the expression of N-terminal huntingtin fragment proteins with 120 polyQ repeats or the full-length Htt protein with 75 repeats downregulated Sigmar1 level in neuronal PC6.3 cells.